Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Interviews
    • Sign up for alerts
  • About us
    • About BiO
    • Editors and Board
    • Editor biographies
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact BiO
    • Advertising
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Biology Open
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Biology Open

Advanced search

RSS   Twitter   Facebook   YouTube

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Interviews
    • Sign up for alerts
  • About us
    • About BiO
    • Editors and Board
    • Editor biographies
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact BiO
    • Advertising
    • Feedback
Research Article
Endurance exercise resistance to lipotoxic cardiomyopathy is associated with cardiac NAD+/dSIR2/PGC-1α pathway activation in old Drosophila
Deng-Tai Wen, Lan Zheng, Jin-xiu Li, Dan Cheng, Yang Liu, Kai Lu, Wen-qi Hou
Biology Open 2019 8: bio044719 doi: 10.1242/bio.044719 Published 17 October 2019
Deng-Tai Wen
1Key Laboratory of Physical Fitness and Exercise Rehabilitation of Hunan Province, Hunan Normal University, Changsha 410012, Hunan Province, China
2Department of Sports Science, Ludong University, Yantai 264025, Shandong Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Deng-Tai Wen
Lan Zheng
1Key Laboratory of Physical Fitness and Exercise Rehabilitation of Hunan Province, Hunan Normal University, Changsha 410012, Hunan Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Lanzheng@hunnu.edu.cn
Jin-xiu Li
1Key Laboratory of Physical Fitness and Exercise Rehabilitation of Hunan Province, Hunan Normal University, Changsha 410012, Hunan Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Cheng
1Key Laboratory of Physical Fitness and Exercise Rehabilitation of Hunan Province, Hunan Normal University, Changsha 410012, Hunan Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yang Liu
1Key Laboratory of Physical Fitness and Exercise Rehabilitation of Hunan Province, Hunan Normal University, Changsha 410012, Hunan Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai Lu
1Key Laboratory of Physical Fitness and Exercise Rehabilitation of Hunan Province, Hunan Normal University, Changsha 410012, Hunan Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen-qi Hou
1Key Laboratory of Physical Fitness and Exercise Rehabilitation of Hunan Province, Hunan Normal University, Changsha 410012, Hunan Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & tables
  • Info & metrics
  • eLetters
  • PDF
Loading

ABSTRACT

Lipotoxic cardiomyopathy is caused by excessive lipid accumulation in myocardial cells and it is a form of cardiac dysfunction. Cardiac PGC-1α overexpression prevents lipotoxic cardiomyopathy induced by a high-fat diet (HFD). The level of NAD+ and Sir2 expression upregulate the transcriptional activity of PGC-1α. Exercise improves cardiac NAD+ level and PGC-1α activity. However, the relationship between exercise, NAD+/dSIR2/PGC-1α pathway and lipotoxic cardiomyopathy remains unknown. In this study, flies were fed a HFD and exercised. The heart dSir2 gene was specifically expressed or knocked down by UAS/hand-Gal4 system. The results showed that either a HFD or dSir2 knockdown remarkably increased cardiac TG level and dFAS expression, reduced heart fractional shortening and diastolic diameter, increased arrhythmia index, and decreased heart NAD+ level, dSIR2 protein, dSir2 and PGC-1α expression levels. Contrarily, either exercise or dSir2 overexpression remarkably reduced heart TG level, dFAS expression and arrhythmia index, and notably increased heart fractional shortening, diastolic diameter, NAD+ level, dSIR2 level, and heart dSir2 and PGC-1α expression. Therefore, we declared that exercise training could improve lipotoxic cardiomyopathy induced by a HFD or cardiac dSir2 knockdown in old Drosophila. The NAD+/dSIR2/PGC-1α pathway activation was an important molecular mechanism of exercise resistance against lipotoxic cardiomyopathy.

INTRODUCTION

Cardiac disease is a major cause of mortality in modern society. The high prevalence of obesity and related diseases, such as lipotoxic cardiomyopathy, plays a significant role in the increased incidence of heart failure. Heart failure affects more than a billion people worldwide. Lipotoxic cardiomyopathy is caused by excessive lipid accumulation in myocardial cells, and it is a form of cardiac dysfunction (Borradaile and Schaffer, 2005). For example, high-fat diet (HFD)-fed flies exhibit increased triglyceride (TG) fat and alterations in insulin/glucose homeostasis, similar to mammalian responses. A HFD also causes cardiac lipid accumulation, cardiac contractility reduction, conduction blocks and severe structural pathologies, reminiscent of diabetic cardiomyopathies (Birse et al., 2010). In addition, increasing evidence shows that inhibition of signaling through insulin, target of rapamycin (TOR), or the lipogenic transcription factor SREBP, or by increasing TG lipolysis, is effective in counteracting excess lipid accumulation as well as the associated cardiac defects in flies (Birse et al., 2010; de Paula et al., 2016; Hardy et al., 2015). These reports suggest that both a HFD and cardiac lipid metabolism genes are closely related to lipotoxic cardiomyopathy.

Sir2 is the most intensively discussed longevity gene in current aging research. Importantly, some studies have shown that Sir2 is involved in lipid metabolism regulation; a screen for obesity-inducing genes in Drosophila larvae pointed to a role for Sir2 in regulating fat metabolism and a response to amino-acid starvation (Reis et al., 2010). Moreover, Sir2 apparently regulates expression of genes involved in fat metabolism, and the lack of Sir2 increases fat deposition under normal conditions and consequently impairs starvation survival of flies (Banerjee et al., 2012). Next, a recent study shows HFD-fed flies exhibit increased body TG levels and decreased body dSir2 expression (Wen et al., 2018). However, it is unclear whether Sir2 can take part into heart lipid metabolism regulation. A recent study has confirmed PGC-1α as a vital antagonist of HFD-induced lipotoxic cardiomyopathy in flies since it plays key roles in mitochondrial biogenesis and electron transport chain assembly (Diop et al., 2015; Dumont et al., 2018). Interestingly, Sir2 expression can alter the transcriptional activity of the mitochondrial biogenesis coactivator PGC-1α, and it catalyzes PGC-1α deacetylation both in vitro and in vivo. Overexpression of Sir2 deacetylase or increasing NAD+ levels activates transcriptional activity of PGC-1α in neurons and increases mitochondrial density (Dabrowska et al., 2016; Lan et al., 2017). Therefore, studying the relationship between cardiac NAD+/dSIR2/PGC-1α pathway and heart lipid metabolism is very important to understand the mechanism of lipotoxic cardiomyopathy formation.

In modern society, exercise combined with a healthy diet is considered the most economical and non-invasive way to prevent and treat obesity (Bales and Porter Starr, 2018). Exercise also improves heart function and decreases incidence of heart failure in both human and Drosophila. Recent studies report that endurance exercise improves cardiac contraction, and it reduces body and heart lipid levels and heart fibrillation in both HFD and aging flies (Wen et al., 2018; Zheng et al., 2017). Similarly, exercise training alters extrinsic modulation of the heart and improves the intrinsic pump capacity of the heart in human, and it also improves quality of life of patients with chronic heart failure (Chrysohoou et al., 2014; Jackson, 2000; “Water exercise safe for troubled hearts”, 2011). In addition, exercise increased muscle NAD+ levels (Green et al., 1992; Koltai et al., 2010) and increasing NAD+ levels activates transcriptional activity of PGC-1α in neurons and increases mitochondrial density (Dabrowska et al., 2016; Lan et al., 2017). Therefore, these results suggest that NAD+/dSIR2/PGC-1α pathway activation may be one of the key mechanisms in which exercise improves heart function and prevents lipotoxic cardiomyopathy.

In this study, to explore whether endurance exercise could resist HFD-induced lipotoxic cardiomyopathy via activating NAD+/dSIR2/PGC-1α signal pathway, experimental flies were fed a HFD and given exercise, and heart dSir2 expression was changed by building UAS/hand-Gal4 system. The heart TG levels and dFAS gene expression were reflected in the lipid metabolism status. In addition, the heart diastolic diameter, systolic diameter, fractional shortening and arrhythmia index were reflected in the heart function. Finally, the cardiac NAD+ levels, dSIR2 protein level, dSir2 mRNA expression and PGC-1α mRNA expression were reflected in the heart NAD+/dSIR2/ PGC-1α pathway status.

RESULTS

Exercise prevented lipotoxic cardiomyopathy and activated cardiac NAD+/dSIR2/PGC-1α pathway in Drosophila

Increasing evidence confirms that heart lipotoxicity impairment can be induced by feeding HFD in both mammals and flies, and the heart contractility and ejection fraction were weakened at the same time (Abdurrachim et al., 2014; Sibouakaz et al., 2016). Lipotoxicity impairment is also accompanied by the dysfunction of some genes in the heart, such as PGC-1α, dFAS, TOR, etc. (Birse et al., 2010; de Paula et al., 2016; Diop et al., 2015). On the contrary, exercise training improves heart function, decreases incidence of heart failure in both mammals and Drosophila, and reduces body and heart fat levels and heart fibrillation (Wen et al., 2018; Zheng et al., 2017). In addition, exercise increased muscle NAD+ levels (Green et al., 1992; Koltai et al., 2010), and the increasing NAD+ levels could activate transcriptional activity of PGC-1α in cells and increase mitochondrial density (Dabrowska et al., 2016; Lan et al., 2017). These results hinted that NAD+/dSIR2/PGC-1α pathway activation may be one of key mechanisms that exercise improved heart function and prevented lipotoxic cardiomyopathy. To identify this hypothesis, fruit flies in this experiment were subjected to exercise intervention and a HFD intervention.

In this study, our results showed that a HFD remarkably increased heart TG levels in untrained-w1118 flies (P<0.01), and it also upregulated heart dFAS expression levels (P<0.01). These were consistent with the results of previous studies. In addition, we found that exercise availably reduced heart TG level and dFAS expression level in both w1118-normal diet (ND) and w1118-HFD flies (P<0.01, P<0.05). Interestingly, the heart TG levels in w1118-high-fat diet+exercise (HFD+E) flies were lower than those in w1118-ND flies (P<0.05). Therefore, we identified that endurance exercise could prevent lipid accumulation by downregulating cardiac dFAS expression level (Fig. 1A,B).

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

The effect of a HFD and exercise on heart lipid accumulation. (A) Heart relative TG level. Results are expressed as the fold difference compared with w1118-ND flies. The sample size was 80 hearts with three biological replicates. (B) Heart dFAS expression level. The sample size was 80 hearts with three biological replicates. A two-way ANOVA was used to identify differences among the ND, ND+E, HFD, and HFD+E groups in w1118 flies. Data are represented as means±s.e.m. *P<0.05; **P<0.01.

For heart function, results displayed that a HFD significantly reduced heart fractional shortening (FS) in untrained w1118 flies (P<0.01), and it also notably decreased heart diastolic diameters in untrained w1118 flies (P<0.05). Exercise significantly increased FS in both w1118-HFD flies and w1118-ND flies (both P<0.05), and it also increased heart diastolic diameters in both w1118-HFD flies and w1118-ND flies (both P<0.05). Importantly, there was no significant difference between w1118-HFD+E flies and w1118-ND flies in FS (P>0.05) (Fig. 2A–C). Moreover, a HFD significantly increased arrhythmia index (AI) in untrained w1118 flies (P<0.05). Exercise reduced AI in w1118-HFD flies (P<0.05). There was no significant difference between w1118-HFD+E flies and w1118-ND flies in AI (P>0.05) (Fig. 2D). These results confirmed that a HFD could weaken heart contractility and increase the risk of arrhythmia in w1118 flies, but endurance exercise could prevent this from happening in a HFD heart (Fig. 2E1–E4).

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

The effect of a HFD and exercise on heart function. (A) Heart diastolic diameters. (B) Heart systolic diameters. (C) Fractional shortening. (D) Arrhythmia index. (E) Illustrating qualitative differences in heart function parameters (10 s): fractional shortening and arrhythmia index; E1: w1118-ND; E2: w1118-ND+E; E3: w1118-HFD; E4: w1118-HFD+E. A two-way ANOVA was used to identify differences among the ND, ND+E, HFD, and HFD+E groups in w1118 flies. Data are represented as means±s.e.m. *P<0.05; **P<0.01. The sample size was 30 hearts.

The results also showed that a HFD significantly reduced cardiac NAD+ level, dSIR2 level, heart dSir2 expression and PGC-1α expression level in untrained w1118 flies (P<0.05, P<0.01). Exercise significantly increased cardiac NAD+ level, dSIR2 level, heart dSir2 expression and PGC-1α expression level in both w1118-HFD flies and w1118-ND flies (P<0.01). Importantly, the cardiac PGC-1α expression levels in w1118-HFD+E flies was higher than that of w1118-ND flies (P<0.05) (Fig. 3A–D). Since the PGC-1α was involved in the synthesis of mitochondria, the number and morphology of mitochondria in cardiac cells was determined by transmission electron microscopy. We observed that in both HFD flies and non-HFD flies, exercise increased mitochondrial numbers and improved myofibril arrangement regularity in myocardial cells (Fig. 3E1–E4). Therefore, these results confirmed that a HFD induced a decreased in heart NAD+/dSIR2/PGC-1α pathway activity, but exercise training could prevent this from happening and even improve heart NAD+/dSIR2/PGC-1α pathway in HFD flies.

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

The effect of a HFD and exercise on NAD+/dSIR2/PGC-1α pathway. (A) Heart NAD+ levels. Results are expressed as the fold difference compared with w1118-ND flies. (B) Heart dSIR2 level. Results are expressed as the fold difference compared with w1118-ND flies. (C) Heart dSir2 mRNA expression level. (D) Heart PGC-1α mRNA expression level. (E) The images of transmission electron microscopy; E1: w1118-ND; E2: w1118-ND+E; E3: w1118-HFD; E4: w1118-HFD+E. As we have seen exercise increased the mitochondrial numbers and improved myofibril arrangement regularity in myocardial cells. The red circle represented the position of the mitochondria in myocardial cells. The arrow represented the position of the Z line in myocardial cells. A two-way ANOVA was used to identify differences among the ND, ND+E, HFD, and HFD+E groups in w1118 flies. Data are represented as means±s.e.m. *P<0.05; **P<0.01. The sample size of these indicators was 80 hearts, with three biological replicates.

Lipotoxic cardiomyopathy and cardiac dSir2 gene in Drosophila

Sir2 is an archetypal longevity gene and founder of the Sirtuin protein family, and it is involved in the regulation of rDNA stability and the control of cellular lifespan and aging (Burnett et al., 2011; Kayashima et al., 2017; Slade and Staveley, 2016; Whitaker et al., 2013). Recent studies report that dSir2 also takes part into the regulation of lipid metabolism (Hoffmann et al., 2013; Wen et al., 2018). For instance, overexpression of dSir2 restricts fat accumulation in individual cells of the fat body in a cell autonomous manner, and loss of the dSir2 leads to the age-progressive onset of hyperglycemia, obesity, glucose intolerance and insulin resistance (Palu and Thummel, 2016; Reis et al., 2010). However, it remains unclear how dSir2 regulates lipid metabolism. Some evidence suggests that Sir2 expression can alter the transcriptional activity of the mitochondrial biogenesis coactivator PGC-1α, and it catalyzes PGC-1α deacetylation both in vitro and in vivo. Overexpression of Sir2 deacetylase or increasing NAD+ levels activate transcriptional activity of PGC-1α in neurons and increases mitochondrial density (Dabrowska et al., 2016; Lan et al., 2017). It has been reported the PGC-1α in fly heart is a key gene in regulating the formation of lipotoxic cardiomyopathy (Diop et al., 2015; Dumont et al., 2018). To confirm the guess that heart dSir2 gene can regulate cardiac lipid metabolism via modulating NAD+/dSIR2/PGC-1α pathway, the cardiac dSir2 gene was overexpressed and knocked down by building UAS/hand-Gal4 system in Drosophila.

Cardiac dSir2 overexpression reduced the risk of lipotoxic cardiomyopathy

In this research, the results showed the cardiac dSir2 mRNA expression of dSir2-overexpression-normal diet (dSir2-OE-ND) flies was higher than that of dSir2-control flies (P<0.01, about 3.1-fold higher) (Fig. 4A). This suggested that cardiac dSir2 gene overexpression was successfully constructed. Since a dnaJ-homologue (dnaJ-H) gene partially overlaps with dSir2, the cardiac dSir2 overexpression might affect cardiac dnaJ-H mRNA expression. To avoid the influence of cardiac dnaJ-H mRNA expression on our results, we measured the expression of dnaJ-H gene in the heart. The results showed that there was no significant difference between dSir2-control flies and dSir2-OE flies in cardiac dnaJ-H mRNA expression (P>0.05) (Fig. 4K). Increasing evidence indicates that moderately increased expression of dSir2 (2.5-fold, threefold, and fivefold) from the native dSir2 locus cannot increase dnaJ-H mRNA expression (Burnett et al., 2011; Hoffmann et al., 2013). In this study, cardiac dSir2 mRNA expression of dSir2-OE-ND flies was about 3.1-fold higher than that of dSir2-control flies. This hinted that cardiac dSir2 overexpression did not significantly affect cardiac dnaJ-H mRNA expression, and cardiac dnaJ-H gene may not affect our results in this study. Also, results showed that cardiac dSir2 overexpression significantly increased heart dSIR2 level, NAD+ level, and PGC-1α expression level (P<0.05, P<0.05, P<0.01) when dSir2-OE-ND flies were compared to dSir2-control flies (Fig. 4B–D). It hinted that cardiac dSir2 gene overexpression upregulated NAD+/dSIR2/PGC-1α pathway activity. Moreover, we found heart diastolic diameter and fractional shortening of dSir2-OE-ND flies were higher than that of dSir2-control flies (P<0.05) (Fig. 4E,G). The arrhythmia index of dSir2-OE-ND flies was lower than that of dSir2-control flies (P<0.05) (Fig. 4H,L). This suggested that cardiac dSir2 gene overexpression could enhance cardiac contractility and decrease the risk of arrhythmia. Finally, we found that the heart TG level and dFAS expression of dSir2-OE-ND flies was lower than that of dSir2-control flies (P<0.01) (Fig. 4-I,J). Therefore, these results indicated that cardiac dSir2 gene overexpression could prevent lipid accumulation in the heart. According to others and our results, we hypothesized that cardiac dSir2 gene overexpression could reduce the risk of lipotoxic cardiomyopathy via activating cardiac NAD+/dSIR2/ PGC-1α pathway in old flies.

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

The effect of a HFD and exercise on lipotoxic cardiomyopathy in dSir2-OE flies. (A) Relative heart dSir2 mRNA expression level. (B) Heart dSIR2 level. (C) Heart NAD+ levels. (D) Relative heart PGC-1α mRNA expression level. (E) Heart diastolic diameter. (F) Heart systolic diameter. (G) Fractional shortening. (H) Arrhythmia index. (I) Heart TG levels. Results are expressed as the fold difference compared with dSir2-control flies. (J) Relative heart dFAS gene expression level. (K) Relative heart dnaJ-H mRNA expression level. (L) Illustrating qualitative differences in heart function parameters (6 s): fractional shortening and arrhythmia index; L1: dSir2-control; L2: dSir2-OE-ND; L3: dSir2-OE-ND+E; L4: dSir2-OE-HFD; L5: dSir2-OE-HFD+E. Independent sample t-test was used to identify differences between dSir2-control flies and dSir2-OE flies. A two-way ANOVA was used to identify differences among the ND, ND+E, HFD, and HFD+E groups in dSir2-OE flies. Data are represented as means±s.e.m. *P<0.05; **P<0.01. The sample size was the same as with w1118.

To further confirm whether cardiac dSir2 gene overexpression could prevent lipotoxic cardiomyopathy induced by a HFD, the dSir2-OE flies were fed a HFD. Results showed that the cardiac dSir2 expression level, dSIR2 level, NAD+ level, PGC-1α expression level, diastolic diameter, fractional shortening, arrhythmia index, heart TG level and dFAS expression of dSir2-OE-ND flies were not significantly different from that of dSir2-OE-HFD flies (P>0.05) (Fig. 4). These results confirmed that cardiac dSir2 gene overexpression could prevent lipotoxic cardiomyopathy induced by a HFD in old flies. The mechanism is that a HFD cannot weaken the activity of NAD+/dSIR2/PGC-1α pathway in dSir2-OE flies.

In w1118 flies, we have confirmed that endurance exercise could resist lipotoxic cardiomyopathy and activate NAD+/dSIR2/PGC-1α pathway, but the relationship between endurance exercise and cardiac dSir2 gene overexpression in preventing lipotoxic cardiomyopathy induced by a HFD remained unknown. So, the dSir2-OE flies participated in exercise training. We found that endurance exercise significantly upregulated the expression of cardiac dSir2 gene in both dSir2-OE-ND flies and dSir2-OE-HFD flies (P<0.01 and P<0.05, respectively) (Fig. 4A), and it also remarkably increased heart dSIR2 level, NAD+ level and PGC-1α expression level in both dSir2-OE-ND flies and dSir2-OE-HFD flies (P<0.05 and P<0.01, respectively) (Fig. 4B–D). In addition, endurance exercise significantly increased diastolic diameter in dSir2-OE-ND flies (P<0.05), and it significantly increased fractional shortening in both dSir2-OE-ND flies and dSir2-OE-HFD flies (P<0.055) (Fig. 4E–G). Moreover, endurance exercise significantly reduced heart TG level and dFAS expression in both dSir2-OE-ND flies and dSir2-OE-HFD flies (P<0.05 and P<0.01, respectively) (Fig. 4I,J). Therefore, in the fight against lipotoxic cardiomyopathy, overexpression of cardiac dSir2 was parallel to exercise training. Overexpression of cardiac dSir2 combined with exercise training could better prevent lipotoxic cardiomyopathy in old flies. The mechanism was that both overexpression of cardiac dSir2 and exercise training could superimpose the improvement of the activity of cardiac NAD+/dSIR2/PGC-1α pathway.

Exercise improved lipotoxic cardiomyopathy induced by cardiac dSir2 knockdown

To further confirm the relationship between cardiac dSir2 and lipotoxic cardiomyopathy, it was necessary to construct cardiac dSir2 knockdown (KD) by UAS/hand-Gal4 system. In this study, the results showed that the cardiac dSir2 mRNA expression of dSir2-KD-ND flies was lower than that of dSir2-control flies (P<0.01, about 2.5-fold lower) (Fig. 5A). It suggested that cardiac dSir2 gene knockdown was successfully constructed. In addition, when dSir2-OE-ND flies were compared to dSir2-control flies, we found cardiac dSir2 knockdown significantly decreased heart dSIR2 levels, NAD+ levels, and PGC-1α expression levels (P<0.01) (Fig. 5B–D). This suggested that cardiac dSir2 gene knockdown inhibited NAD+/dSIR2/PGC-1α pathway activity. Moreover, we found the heart diastolic diameter and fractional shortening of dSir2-KD-ND flies were lower than that of dSir2-control flies (P<0.05, P<0.01) (Fig. 5E,G). The arrhythmia index of dSir2-KD-ND flies was higher than that of dSir2-control flies (P<0.05) (Fig. 5H,K). This suggested that cardiac dSir2 gene knockdown could weaken cardiac contractility and increase the risk of arrhythmia. Finally, we found that the heart TG levels and dFAS expression of dSir2-KD-ND flies were higher than that of dSir2-control flies (P<0.01) (Fig. 5I,J). This indicated that cardiac dSir2 gene knockdown could induce lipid accumulation in the heart. Therefore, according to others’ and our own evidence, we hypothesized that cardiac dSir2 gene knockdown could induce lipotoxic cardiomyopathy via inhibiting cardiac NAD+/dSIR2/ PGC-1α pathway in old flies.

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

The effect of a HFD and exercise on lipotoxic cardiomyopathy in dSir2-KD flies. (A) Relative heart dSir2 mRNA expression level. (B) Heart dSIR2 level. (C) Heart NAD+ levels. (D) Relative heart PGC-1α mRNA expression level. (E) Heart diastolic diameter. (F) Heart systolic diameter. (G) Fractional shortening. (H) Arrhythmia index. (I) Cardiac TG level. Results are expressed as the fold difference compared with dSir2-control flies. (J) Relative heart dFAS gene expression level. (K) Illustrating qualitative differences in heart function parameters (10 s): fractional shortening and arrhythmia index; K1: dSir2-control; K2: dSir2-KD-ND; K3: dSir2- KD-ND+E; K4: dSir2- KD-HFD; K5: dSir2-KD-HFD+E. Independent sample t-test was used to identify differences between dSir2-control flies and dSir2-KD flies. A two-way ANOVA was used to identify differences among the ND, ND+E, HFD, and HFD+E groups in dSir2-OE flies. Independent sample t-test was used to identify differences between dSir2-control flies and dSir2-KD flies. Data are represented as means±s.e.m. *P<0.05; **P<0.01. The sample size was the same as with w1118.

Although it had been confirmed that a HFD could induce lipotoxic cardiomyopathy in w1118 flies, it remained unclear whether lipotoxic cardiomyopathy, induced by cardiac dSir2 knockdown, could be aggravated after a HFD intervention. To figure this out, the cardiac dSir2 gene knockdown flies were fed a HFD. Results showed that the cardiac dSir2 expression level, dSIR2 level, NAD+ level and PGC-1α expression level of dSir2-KD-HFD flies were lower than that of dSir2-KD-ND flies (P<0.05) (Fig. 5A–D). This suggested that a HFD could reduce cardiac dSir2 gene expression and the activity of NAD+/dSIR2/PGC-1α pathway in untrained dSir2-KD flies. In addition, heart diastolic diameter and fractional shortening of dSir2-KD-HFD flies were lower than that of dSir2-KD-ND flies (P<0.05, P<0.01) (Fig. 5E,G), and the arrhythmia of dSir2-KD-HFD flies was higher than that of dSir2-KD-ND flies (P<0.05) (Fig. 5H,K). It indicated that a HFD could weaken cardiac contractility and increase the risk of arrhythmia in untrained dSir2-KD flies. What is more, the heart TG level and dFAS expression of dSir2-KD-HFD flies were higher than that of dSir2-KD-ND flies (P<0.05, P<0.01) (Fig. 5I,J). It also indicated that a HFD could increase cardiac lipid accumulation in untrained dSir2-KD flies. So, these results confirmed that a HFD could aggravate lipotoxic cardiomyopathy induced by cardiac dSir2 knockdown via inhibiting cardiac NAD+/dSIR2/PGC-1α pathway in untrained flies.

Although it had been identified that exercise could prevent lipotoxic cardiomyopathy induced by a HFD in w1118 flies, and although exercise combined with overexpression of cardiac dSir2 could better prevent lipotoxic cardiomyopathy in old flies, it remained unknown as to whether endurance exercise could improve lipotoxic cardiomyopathy induced by cardiac dSir2 knockdown, and whether endurance exercise could prevent further deterioration of lipotoxic cardiomyopathy induced by a HFD in cardiac dSir2 knockdown flies. To figure this out, the dSir2-KD-ND flies and dSir2-KD-HFD flies were given exercise training. Results showed that endurance exercise significantly upregulated the expression of cardiac dSir2 gene in both dSir2-KD-ND flies and dSir2-KD-HFD flies (P<0.01) (Fig. 5A), and it also remarkably increased heart dSIR2 level, NAD+ level and PGC-1α expression level in both dSir2-KD-ND flies and dSir2-KD-HFD flies (P<0.05 and P<0.01, respectively) (Fig. 5B–D). In addition, endurance exercise significantly increased diastolic diameter and fractional shortening in both dSir2-KD-ND flies and dSir2-KD-HFD flies (P<0.05 and P<0.01, respectively) (Fig. 5E,G), and it significantly decreased arrhythmia index in both dSir2-KD-ND flies and dSir2-KD-HFD flies (P<0.05 and P<0.01, respectively) (Fig. 5H,K). Moreover, endurance exercise significantly reduced heart TG level and dFAS expression in both dSir2-KD-ND flies and dSir2-KD-HFD flies (P<0.01) (Fig. 5I,J). Therefore, we hypothesized that endurance exercise could improve lipotoxic cardiomyopathy induced by cardiac dSir2 knockdown, and it could prevent further deterioration of lipotoxic cardiomyopathy induced by a HFD in cardiac dSir2 knockdown flies.

However, to find out the extent to which exercise saved lipotoxic cardiomyopathy in both dSir2-KD-ND flies and dSir2-KD-HFD flies, the dSir2-KD-HFD+E flies were compared with dSir2-KD-ND flies, and the dSir2-KD-ND flies and dSir2-KD-HFD flies were compared with dSir2-control flies. Interestingly, the cardiac dSir2 expression level, dSIR2 level, NAD+ level, PGC-1α expression level, diastolic diameter and fractional shortening of dSir2-KD-HFD+E flies were higher than that of dSir2-KD-ND flies (P<0.05 and P<0.01, respectively) (Fig. 5A–E,G). The arrhythmia index, heart TG level, and dFAS expression of dSir2-KD-HFD+E flies were lower than that of dSir2-KD-ND flies (P<0.05, P<0.01) (Fig. 5H–J). Moreover, the cardiac dSir2 expression level, dSIR2 level, NAD+ level, PGC-1α expression level, diastolic diameter, fractional shortening, arrhythmia index, heart TG level and dFAS expression of dSir2-KD-ND flies and dSir2-KD-HFD flies were not significantly different from that of dSir2-KD-HFD flies (P>0.05) (Fig. 5). So, we confirmed that endurance exercise could resist and treat lipotoxic cardiomyopathy induced by a HFD and cardiac dSir2 knockdown flies.

DISCUSSION

Lipotoxic cardiomyopathy induced by a HFD related to inhibiting NAD+/dSIR2/PGC-1α pathway

Increasing evidence showed that a HFD could induce lipotoxic cardiomyopathy, which manifested as cardiac lipid accumulation, reduced cardiac contractility, increased risk of arrhythmia and severe structural pathologies in flies (Birse et al., 2010; Diop et al., 2015; Na et al., 2013; Wen et al., 2018). Similarly, our results confirmed again that a HFD could induce lipotoxic cardiomyopathy. For example, a HFD increased the heart TG level and the heart dFAS expression levels, and it resulted in heavy lipid accumulation. In addition, a HFD reduced heart fractional shortening via decreasing diastolic diameter, and it increased arrhythmia indexes. These changes easily led to heart dysfunction and heart failure (Axell et al., 2015; Kang et al., 2016; Vaduganathan et al., 2018). Moreover, the heart NAD+ levels, dSIR2 levels, dSir2 gene expression levels and PGC-1α expression were all decreased after feeding a HFD. These results suggested the heart NAD+/dSIR2/PGC-1α pathway activation was inhibited by a HFD.

Accumulating studies indicated that HFD-induced obesity could decrease the levels of NAD+ by several ways. For example, the mitochondria had compromised function due to overload that was thought to be induced by excessive beta-oxidation, and HFD-induced obesity could also decrease the mitochondrial numbers (Agil et al., 2015; Yoshino et al., 2011). Since there was a NAD+ pool in mitochondrial, NAD+ levels in metabolic tissues decreased with obesity (Alano et al., 2007; Di Lisa et al., 2001; Sauve, 2008). In addition, the oxidative stress by a HFD also caused an increased in lipid peroxidation, and the increased oxidative stress accumulated fat was an important pathogenic mechanism of metabolic syndromes associated with obesity (de Paula et al., 2016; Roberts et al., 2006). A number of studies had demonstrated that oxidative stress induced excessive PARP-1 activation mediates cell death, and NAD+ depletion mediates PARP-1-induced cell death, which indicated that HFD-induced increased oxidative stress could also reduce NAD+ level via PARP-1 activation mediated cell death (Horton et al., 2005; Konecny and Kristeleit, 2016; Massudi et al., 2012; Morales et al., 2014; Pang et al., 2015). NAD+ depletion lead to abnormal hepatic lipid metabolism in HFD-induced nonalcoholic fatty liver disease (Zhang et al., 2014). Therefore, these reports hinted that a HFD induced decreased NAD+ levels in cells.

In HFD flies, because of the lipotoxicity the reduction of cardiac NAD+ content inhibited dSIR2 (NAD-dependent histone deacetylases) activity. Since PGC-1α was a key antagonist of HFD-induced lipotoxic cardiomyopathy, and since PGC-1α was activated by the NAD+-dependent deacetylate of SIR2 (Arany et al., 2008; Rodgers et al., 2005), HFD-induced the reduction of NAD+ content decreased PGC-1α activation via inhibiting dSIR2 activation. This finally led to a more severe mitochondria number reduction, lipid accumulation, and dysfunction in the heart of HFD-fed flies. These findings suggested that the activity of NAD+/dSIR2/PGC-1α pathway was closely related to the formation of lipotoxic cardiomyopathy in flies. However, to confirm the relationship between NAD+/dSIR2/PGC-1α pathway and lipotoxic cardiomyopathy, further experiments should be done.

Cardiac dSir2 gene involved into regulating the formation of lipotoxic cardiomyopathy

It had been proposed that Sir2 in the fat body plays an important role in regulating fat storage and mobilization, as Sir2/Sirt1 had been implicated in regulation of fat metabolism in flies and mammals. Overexpression of Sir2 in the adult fat body was found to be sufficient to extend the lifespan of male and female Drosophila (Boutant and Cantó, 2016; Hoffmann et al., 2013; Knight and Milner, 2012). However, it remains unclear whether Sir2 can regulate heart lipid metabolism and cardiac function.

As expected, our research showed that the dSir2 gene could also regulate lipid metabolism in the heart. For example, overexpression of cardiac dSir2 gene could not only reduce heart TG accumulation and heart dFAS expression, but also it could prevent heart TG accumulation and decrease heart dFAS expression induced by a HFD. While cardiac dSir2 knockdown could increase heart TG accumulation and heart dFAS expression, and this would get worse under a HFD intervention. The dSir2 apparently regulates expression of genes involved in fat metabolism, and lack of Sir2 increases fat deposition under normal conditions and consequently impairs starvation survival capabilities of flies (Banerjee et al., 2012). It has been reported that the FOXO and PGC-1α activity can be modulated by SIR2 deacetylation (Dabrowska et al., 2016; Lan et al., 2017), and these two factors are important to the formation of lipotoxic cardiomyopathy in Drosophila (Diop et al., 2015; Dumont et al., 2018). However, there is no direct evidence that cardiac Sir2 can regulate heart lipid metabolism via activating PGC-1α activity in Drosophila.

In this study, we also found that cardiac dSir2 gene had the ability to modulate cardiac function. For instance, overexpression of cardiac dSir2 gene could increase heart fractional shortening via increasing diastolic diameter, and overexpression of cardiac dSir2 gene could decrease arrhythmia index. In addition, overexpression of cardiac dSir2 gene could prevent fractional shortening decline and arrhythmia index increase induced by a HFD. Also, cardiac dSir2 knockdown could decrease heart fractional shortening via decreasing diastolic diameter, and cardiac dSir2 knockdown could increase arrhythmia index. A HFD intervention could aggravate cardiac systolic dysfunction and arrhythmia in cardiac dSir2 knockdown flies. It has been reported that FOXO or PGC-1α knockdown results in serious cardiac dysfunction in flies, including reduced cardiac contractility and increased the risk of arrhythmia (Diop et al., 2015; Dumont et al., 2018). The activity of PGC-1α can be modulated by SIR2 deacetylation (Dabrowska et al., 2016; Lan et al., 2017). However, there was no direct evidence that cardiac dSir2 could regulate heart function via activating PGC-1α activity in Drosophila.

To confirm whether cardiac dSir2 gene could regulate lipotoxic cardiomyopathy by modulating cardiac NAD+/ dSIR2/PGC-1α pathway, the cardiac dSIR2 level, NAD+ level and PGC-1α expression levels were measured. We found overexpression of cardiac dSir2 gene increased cardiac dSIR2 level, NAD+ level, and PGC-1α expression level, and overexpression of cardiac dSir2 gene could prevent the decline of cardiac dSIR2 level, NAD+ level, and PGC-1α expression level induced by a HFD. On the other hand, cardiac dSir2 knockdown decreased cardiac dSIR2 level, NAD+ level, and PGC-1α expression level. A HFD intervention could aggravate the decline of cardiac dSIR2 level, NAD+ level, and PGC-1α expression level in cardiac dSir2 knockdown flies.

SIR2 directly binds to PGC-1α and deacetylated it in 293T cells and PC12 cells (Li et al., 2016). SIR2 stimulates the ability of PGC-1α to coactivate hepatocyte nuclear factor 4α, thereby positively regulating gluconeogenic genes in response to pyruvate in hepatic cells. In the same cell type, SIR2 also enhances the ability of PGC-1α to inhibit glycolytic genes in response to pyruvate (Yang et al., 2014). Furthermore, SIR2 affects fatty acid oxidation in adipocytes and knockdown of PGC-1α cancels the effect of overexpression of SIR2 upon fatty acid oxidation. Thus the availability of other family members also contributes to the net effect of sirtuins upon PGC-1α (Tang, 2016). Systemic deletion of SIR2 in mice induces the development of dilated cardiomyopathy, which is accompanied by mitochondrial dysfunction. Overexpression of SIR2 in pancreatic β-cells enhances insulin secretion in response to glucose and improves glucose metabolism by increasing ATP production via suppression of uncoupling protein-2 expression (Cao et al., 2016; Luu et al., 2013).

In this research, we identified that cardiac dSir2 gene could regulate PGC-1α expression via NAD+ and dSIR2 level. This possibly caused dysfunction of the heart's mitochondria, and this could induce lipid accumulation and reduced contractile ability of the heart, and eventually result in lipotoxic cardiomyopathy. A previous study has confirmed that when PGC-1 was overexpressed in heart, lipotoxic cardiomyopathy was prevented after flies were fed a HFD (Diop et al., 2015). Similarly, overexpression of dSir2 also resisted lipotoxic cardiomyopathy induced by a HFD in this study. Therefore, based on this evidence, we declared that the activation of cardiac NAD+/dSIR2/PGC-1α pathway was a key pathway that regulated the formation of lipotoxic cardiomyopathy.

Exercise improved lipotoxic cardiomyopathy induced by a HFD and dSir2 knockdown in old Drosophila

A lot of studies have confirmed that appropriate endurance exercise is a healthy and economical way to prevent and cure obesity, and endurance exercise is also considered a good way to improve heart functional in obese or old individuals (Stanley et al., 2019). For example, exercise training can strengthen the heart's ability to use fatty acids to provide energy by increasing the activity of related enzymes, which prevents lipid excessive accumulation in the heart (Wang and Xu, 2017). Furthermore, exercise training improves heart function such as cardiac contractibility and exercise reduces heart failure in obese individuals (Goit, 2017; Kwak, 2013; May et al., 2016; Voulgari et al., 2013). Finally, exercise increases muscle NAD+ levels and neuron NAD+ levels, and it activates transcriptional activity of PGC-1α and increases mitochondrial density (Dabrowska et al., 2016; Green et al., 1992; Koltai et al., 2010; Lan et al., 2017). However, it remains unclear whether exercise can prevent lipotoxic cardiomyopathy by activating cardiac NAD+/dSIR2/PGC-1α pathway.

In this research, we found that in HFD-fed flies, the heart TG level and the heart dFAS expression level were significantly decreased after exercise training. In addition, exercise training increased heart fractional shortening via increasing diastolic diameters, and exercise training decreased arrhythmia index in a HFD-fed flies and cardiac dSir2 knockdown flies. Finally, the heart NAD+ levels, dSIR2 levels, dSir2 gene expression levels and PGC-1α expression were all increased after exercise training in HFD-fed flies. This suggested that exercise training reduced lipid accumulation, improved heart function, activated NAD+/dSIR2/PGC-1α pathway and reduced the risk of arrhythmia, which prevented lipotoxic cardiomyopathy formation.

In HFD-fed flies, on one hand, exercise training can strengthen the heart's ability to use fatty acids to provide energy by increasing the activity of related enzymes, which prevents excessive lipid accumulation in the heart (Wang and Xu, 2017). On the other hand, because the dSIR2 protein plays a pivotal role in PGC-1α function via NAD-dependent deacetylation (Huang et al., 2015; Jünger et al., 2003; Kobayashi et al., 2005; Rizki et al., 2011), and because the PGC-1α is a key antagonist of HFD-induced lipotoxic cardiomyopathy (Birse et al., 2010; Haemmerle et al., 2011; Puigserver et al., 1998; Wessells et al., 2004), exercise training increased the PGC-1α function via improving heart NAD+ content and heart dSIR2 activation in this study (Dabrowska et al., 2016; Green et al., 1992; Koltai et al., 2010; Lan et al., 2017). Therefore, these results suggested that the NAD+/dSIR2/PGC-1α pathway activation was an important molecular mechanism of exercise resistance against lipotoxic cardiomyopathy. However, it remained unclear whether exercise training could improve lipotoxic cardiomyopathy induced by cardiac dSir2 knockdown.

In this study, the heart dSir2-RNAi flies were exercise trained and we found exercise training also reduced lipid accumulation, enhanced heart function, activated NAD+/dSIR2/PGC-1α pathway, and reduced the risk of arrhythmia, which improved lipotoxic cardiomyopathy induced by heart dSir2 RNAi. In heart dSir2-RNAi flies, exercise training can also increase the cardiac ability to use fatty acids to provide energy by increasing the activity of related enzymes, which prevents lipid excessive accumulation in the heart (Wang and Xu, 2017). In addition, increasing evidence hints that exercise training can upregulate dSir2 activity. For instance, it has been reported that exercise not only improves blood NAD+ levels but also in muscle and cardiac NAD+ levels (Cantó et al., 2010; Fukuwatari et al., 2001; Touati et al., 2015), which may eventually result in increasing NAD+ activity in these tissues and organs to meet the demand of NAD+ metabolism during exercise training. Since the dSir2 activity can be regulated by free NAD+ in cells, the dSir2 expression may be indirectly elevated by exercise trained (Gambini et al., 2011). Moreover, increasing evidence indicates that exercise can intensify the contraction of cardiac muscles which may facilitate SIRT1 upregulation. Exercise training can upregulate heart AMPK expression – AMPK is an energy sensor. Since AMPK also increases the intracellular NAD+ levels, its activity is correlated with SIRT1 enhancement (Chen et al., 2018; Lavu et al., 2008). Next, recent studies report that exercise training upregulates SIRT1 in kidney, liver and brain (Huang et al., 2019; Liu et al., 2019). So, these reports suggest that exercise training can increase Sir2 expression. However, there is no evidence that exercise training can increase heart dSir2 expression by affecting the UAS/Gal4 system. Besides, in our experiment, a stronger cardiac dSir2 knockdown has not been generated any other way, such as with an inducible CRISPR or a stronger RNAi line or stronger driver. Therefore, our results indicated that exercise training rescued the cardiac dSir2 expression and dSir2 protein levels only under this mild dSir2-knockdown condition, and the reason may be that exercise induction of cardiac dSir2 was stronger than knockdown.

In conclusion, we identified that the heart dSir2 gene and dSir2/NAD+/PGC-1α pathway regulated the heart lipid metabolism and the formation of lipotoxic cardiomyopathy. Lipotoxic cardiomyopathy could be induced by heart dSir2 knockdown, but the heart dSir2 overexpression could prevent a HFD-induced lipotoxic cardiomyopathy. Exercise training could improve lipotoxic cardiomyopathy induced by a HFD or heart dSir2 knockdown in old Drosophila. The NAD+/dSIR2/PGC-1α pathway activation was an important molecular mechanism of exercise resistance against lipotoxic cardiomyopathy.

MATERIALS AND METHODS

Fly stocks, diet and husbandry

The w1118 and hand-Gal4 line was a gift from Xiu-shan Wu (Heart Development Center of Hunan Normal University). UAS-dSir2-OE (w1118;P{EP}Sirt1EP2300DnaJ-HEP2300/CyO) line was obtained from the Bloomington Stock Center, and the P{EP} construct carries Scer\UAS binding sites for the Scer\GAL4 transcriptional regulator, and bacterial sequences that allow plasmid rescue. The Gal4-UAS system allows regulated expression of genes proximate to the site of the insertion: genes properly oriented with respect to the Scer\UAS sequences can be conditionally expressed via transgene-derived Scer\GAL4 activity (Rorth, 1996). UAS-dSir2-KD (w1118; P{GD11580}v23201) line was obtained from the Vienna Drosophila RNAi Center. Male hand-Gal4 flies were crossed to female UAS-dSir2-OE flies and UAS-dSir2-KD flies.

To avoid the influence of genetic background differences on the results, maternal origin was used as the genetic control. The female ‘w1118;P{EP}Sirt1EP2300DnaJ-HEP2300/CyO’ and ‘hand-Gal4>w1118;P{EP}Sirt1EP2300DnaJ-HEP2300/CyO’ were represented as ‘dSir2-control’ and ‘dSir2-OE’. The female ‘w1118; P{GD11580} v23201’ and ‘hand-Gal4>w1118; P{GD11580} v23201’ were represented as ‘dSir2-control’ and ‘dSir2-KD’. The female ‘w1118’, ‘dSir2-OE’, and ‘dSir2-KD’ virgin flies were divided into several groups: normal-diet (ND) group, normal-diet +exercise (ND+E) group, high-fat diet (HFD) group, and HFD+exercise (HFD+E) group.

Normal food contained 10% yeast, 10% sucrose and 2% agar. The HFD was made by mixing 30% coconut oil with the food in a weight to volume ratio with the normal food (Birse et al., 2010). Both HFD+E group flies and HFD-E group flies were fed the HFD from 28 days of age and were exposed to the HFD for 5 consecutive days. During the experimental time course, flies were housed in a 22±1°C incubator with 50% humidity and a 12-h light/dark cycle. This environment could keep the coconut oil food in a solid state since the melting point of coconut oil is about 24°C, thus ensuring that flies would not get stuck in the oily food. Fresh food was provided every other day for the duration of the experiment. All group flies were raised to the fourth weekend. Flies were trained or fed a HFD at 5 weeks old as we found flies were very sensitive to exercise or HFDs at this time.

Exercise training device and protocols

The advantage of the flies' natural negative geotaxis behavior was taken to induce upward walking when constructing the exercise device (Tinkerhess et al., 2012). All exercise group flies started exercise from when they were 5 weeks old, and underwent a 5-day-long exercise program. Vials were loaded horizontally into a steel tube that was rotated about its horizontal axis by an electric motor, with a gear regulating its shaft speed. There were 25 flies in each vial. Thus, each vial was rotated along its long axis with the accompanying rotating steel tube, which made the flies climb. Most flies continued to respond by climbing throughout the exercise period. The few that failed to climb were actively walking at the inner wall of the vial (Wen et al., 2016; Zheng et al., 2015). Flies were exercised in vials with a 2.8-cm inner diameter, rotated at 0.14 rev/s. Flies were exercised for 1.5 hours every time.

Semi-intact Drosophila preparation and image analysis

First, 30 flies were anesthetized with FlyNap for 2–3 min (a few flies were anesthetized with FlyNap for 4–5 min as they were hard to narcotize). Next, the head, ventral thorax and ventral abdominal cuticle were removed by special scissors and tweezers to expose the heart in the field of vision of a microscope. Note, dissections were done under oxygenated artificial hemolymph. These semi-intact preparations were allowed to equilibrate with oxygenation for 15–20 min before filming. Finally, image analysis of heart contractions was performed using high-speed videos of the preparations. Videos were taken 120–130 frames per second using a Hamamatsu EM-CCD digital camera on a Leica DM LFSA microscope with a 10 immersion lens. To get a random sampling of heart function, a single 30-s recording was made for each fly. All images were acquired and contrast enhanced by using Simple PCI imaging software. The heart physiology of the flies was assessed using a semi-automated optical heartbeat analysis program that quantifies heart diastolic diameters, systolic diameters, fractional shortening and arrhythmia index (Fink et al., 2009).

The SIRT1/dSIR2 assay, NAD+ assay, and TG assay

For dSIR2 assay, 80 hearts were homogenized in 200 μl PBS buffer. To break the cells, hearts were subjected to freeze-thaw cycles. The homogenates were then centrifuged for 5 min at 5000×g to get the supernate as a sample. We used purified insect SIRT1 antibody to coat microtiter plate wells, made the solid-phase antibody, then added SIRT1 to the wells, which, combined with HRP-labelled antibody, become antibody-antigen-enzyme-antibody complex. Then we added 50 μl standard sample liquid and experimental sample liquid to different wells. 100μl of HRP-conjugate reagent was added to each well, which were then incubated for 60 min at 37°C. 50 μl Chromogen Solution A and Chromogen Solution B were added to each well, which were kept in the dark for 15 min at 37°C. Next 50 μl of Stop Solution was added to each well to stop the reaction (a color change from blue to yellow was observed). The blank well was taken as zero, absorbance was read at 450 nm after adding Stop Solution and within 15 min. The OD values were used to determine sample Sirt1 concentration from the standard curve according to the manufacturer's instructions (Insect SIRT1 ELISA Kit, MLBIO).

For NAD+ assay, 80 hearts were homogenized in 200 μl NAD exaction buffer, and then extracts were heated at 70°C for 5 min. 20 μl assay buffer and 100 μl of the opposite extraction to neutralize the extracts were added. Samples were centrifuged at 14,000 rpm for 5 min and then 40 μl standard sample liquid and experimental sample liquid were transferred to separate wells. 80 μl of working reagent (40 μl assay buffer, 1 μl oxidation-reduction enzyme, 10 μl 10% ethanol, 20 μl PMS, 20 μl MTT) was quickly added to each well. The resulting samples were then measured at 565 nm with a microplate spectrophotometer. The OD values were used to determine sample NAD+ concentration from the standard curve according to the manufacturer's instructions (EnzyChrom™NAD+/NADH assay kit).

Cardiac TG measurements were taken from the hearts of 20 female flies dissected in artificial hemolymph. Care was taken to remove as much adipose tissue and other heart-associated cells from the heart as possible. Preparations were washed two times with PBS. Using fine forceps, the hearts were pulled off from the cuticle and transferred into Eppendorf tubes containing 26 μl of PBST (PBS+0.05% Triton X-100). Tubes were immediately frozen and stored at −80°C. Hearts were then mildly sonicated to lyse the cells. 20 μl heart lysates was transferred to a 96-well plate containing 200 μl of lipid reagent. After incubating 10′ at 37°C, 3 μl of heart lysate was transferred to wells containing 200 μl of Bradford reagent to measure protein content. The reaction mixture was incubated in an Environ Shaker at 300 rpm at 37°C for 10 min; the OD 550 nm was measured using SpectraMax Molecular Devices Corp and compared with a standardized curve. Experiments were repeated at least three times in multiple replicates.

qRT-PCR

To check the transcriptional expression of the dSir2, dFAS and PGC-1α gene, 80 flies' hearts were homogenized in Trizol for each group. Firstly, 10 μg of the total RNA was purified by organic solvent extraction from the Trizol (TRIzol, Invitrogen). Next, the purified RNA was treated with DNase I (RNase-free, Roche) and used to produce oligo dT-primed cDNAs (SuperScript II RT, Invitrogen), which were then used as templates for quantitative real-time PCR. The rp49 gene was used as an internal reference for normalizing the quantity of total RNAs. Finally, Real-time PCR was performed with SYBR green using an ABI7300 Real time PCR Instrument (Applied Biosystems). Expression of the various genes was determined by the comparative CT method (ABI Prism 7700 Sequence Detection System User Bulletin #2, Applied Biosystems). Primer sequences of dSir2 were as follows: F: 5′-GCAGTGCCAGCCCAATAA-3′; R: 5′-AGCCGATCACGATCAGTAGA-3′. Primer sequences of PGC-1α were as follows: F: 5′-TGTTGCTG CTACTGCTGCTT-3′; R: 5′-GCCTCTGCATCACCTACA CA-3′. Primer sequences of dFAS were as follows: F: 5′-GGTGAGACCATCGTGGAAGT-3′; R: 5′-AATGTCTGCCAAGCCAGAGT-3′. Primer sequences of dnaJ-H were as follows: F: 5′-GCAAGATGGCACACGTAGCTG-3′; R: 5′-CCACTGTAGCAAC ACGTAATCACC-3′. Primer sequences of Internal were as follows: F: 5′-CTAAGCTGTC GCACAAATGG-3′; R: 5′-AA CTTCTTG AATCCGGTGGG-3′.

Statistical analyses

A two-way ANOVA was used to identify differences among the ND, ND+E, HFD, and HFD+E groups of Drosophila with the same genetic background. Independent sample t-test was used to identify differences between dSir2-control flies and dSir2-OE flies. Analyses were performed using the Statistical Package for the Social Sciences (SPSS) version 16.0 for Windows (SPSS Inc., Chicago, USA), with statistical significance set at P<0.05. Data are represented as means±s.e.m.

Acknowledgements

The authors thank Xiu-shan Wu (The Center for Heart Development, College of Life Science, Hunan Normal University) for supporting Drosophila of w1118 and heart Shoot software technology. We also thank Karen Ocorr and Rolf Bodmer (Neuroscience and Aging Research Center, Sanford Burnham Medical Research Institute) for supporting semi-automatic optical echocardiography analysis software.

Footnotes

  • Competing interests

    The authors declare no competing or financial interests.

  • Author contributions

    Methodology: D.-T.W., D.C., Y.L.; Software: L.Z., Y.L.; Formal analysis: J.-x.L., K.L., W.-q.H.; Resources: D.-T.W., L.Z.; Data curation: J.-x.L., K.L., W.H.; Writing - original draft: D.-T.W.; Funding acquisition: L.Z.

  • Funding

    This work was supported by the National Natural Science Foundation of China [No. 31671243] and the Ministry of Education funding PhD programs [No. 20134306110009].

  • Received May 13, 2019.
  • Accepted September 23, 2019.
  • © 2019. Published by The Company of Biologists Ltd
http://creativecommons.org/licenses/by/4.0

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    1. Abdurrachim, D.,
    2. Ciapaite, J.,
    3. Wessels, B.,
    4. Nabben, M.,
    5. Luiken, J. J. F. P.,
    6. Nicolay, K. and
    7. Prompers, J. J.
    (2014). Cardiac diastolic dysfunction in high-fat diet fed mice is associated with lipotoxicity without impairment of cardiac energetics in vivo. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1841, 1525-1537. doi:10.1016/j.bbalip.2014.07.016
    OpenUrlCrossRef
  2. ↵
    1. Agil, A.,
    2. El-Hammadi, M.,
    3. Jiménez-Aranda, A.,
    4. Tassi, M.,
    5. Abdo, W.,
    6. Fernández-Vázquez, G. and
    7. Reiter, R. J.
    (2015). Melatonin reduces hepatic mitochondrial dysfunction in diabetic obese rats. J. Pineal Res. 59, 70-79. doi:10.1111/jpi.12241
    OpenUrlCrossRef
  3. ↵
    1. Alano, C. C.,
    2. Tran, A.,
    3. Tao, R.,
    4. Ying, W.,
    5. Karliner, J. S. and
    6. Swanson, R. A.
    (2007). Differences among cell types in NAD(+) compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes. J. Neurosci. Res. 85, 3378-3385. doi:10.1002/jnr.21479
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Arany, Z.,
    2. Foo, S.-Y.,
    3. Ma, Y.,
    4. Ruas, J. L.,
    5. Bommi-Reddy, A.,
    6. Girnun, G.,
    7. Cooper, M.,
    8. Laznik, D.,
    9. Chinsomboon, J.,
    10. Rangwala, S. M. et al.
    (2008). HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1 alpha. Nature 451, 1008-1012. doi:10.1038/nature06613
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Axell, R. G.,
    2. Hoole, S. P.,
    3. Hampton-Till, J. and
    4. White, P. A.
    (2015). RV diastolic dysfunction: time to re-evaluate its importance in heart failure. Heart Fail. Rev. 20, 363-373. doi:10.1007/s10741-015-9472-0
    OpenUrlCrossRef
  6. ↵
    1. Bales, C. W. and
    2. Porter Starr, K. N.
    (2018). Obesity interventions for older adults: diet as a determinant of physical function. Adv. Nutr. 9, 151-159. doi:10.1093/advances/nmx016
    OpenUrlCrossRef
  7. ↵
    1. Banerjee, K. K.,
    2. Ayyub, C.,
    3. Sengupta, S. and
    4. Kolthur-Seetharam, U.
    (2012). dSir2 deficiency in the fatbody, but not muscles, affects systemic insulin signaling, fat mobilization and starvation survival in flies. Aging 4, 206-223. doi:10.18632/aging.100435
    OpenUrlCrossRefPubMed
  8. ↵
    1. Birse, R. T.,
    2. Choi, J.,
    3. Reardon, K.,
    4. Rodriguez, J.,
    5. Graham, S.,
    6. Diop, S.,
    7. Ocorr, K.,
    8. Bodmer, R. and
    9. Oldham, S.
    (2010). High-fat-diet-induced obesity and heart dysfunction are regulated by the TOR pathway in Drosophila. Cell Metab. 12, 533-544. doi:10.1016/j.cmet.2010.09.014
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Borradaile, N. M. and
    2. Schaffer, J. E.
    (2005). Lipotoxicity in the heart. Curr. Hypertens. Rep. 7, 412-417. doi:10.1007/s11906-005-0035-y
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Boutant, M. and
    2. Cantó, C.
    (2016). SIRT1: a novel guardian of brown fat against metabolic damage. Obesity 24, 554-554. doi:10.1002/oby.21432
    OpenUrlCrossRef
  11. ↵
    1. Burnett, C.,
    2. Valentini, S.,
    3. Cabreiro, F.,
    4. Goss, M.,
    5. Somogyvari, M.,
    6. Piper, M. D.,
    7. Hoddinott, M.,
    8. Sutphin, G. L.,
    9. Leko, V.,
    10. McElwee, J. J. et al.
    (2011). Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477, 482-485. doi:10.1038/nature10296
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Cantó, C.,
    2. Jiang, L. Q.,
    3. Deshmukh, A. S.,
    4. Mataki, C.,
    5. Coste, A.,
    6. Lagouge, M.,
    7. Zierath, J. R. and
    8. Auwerx, J.
    (2010). Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11, 213-219. doi:10.1016/j.cmet.2010.02.006
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Cao, Y.,
    2. Jiang, X.,
    3. Ma, H. J.,
    4. Wang, Y.,
    5. Xue, P. and
    6. Liu, Y.
    (2016). SIRT1 and insulin resistance. J. Diabetes Complicat. 30, 178-183. doi:10.1016/j.jdiacomp.2015.08.022
    OpenUrlCrossRefPubMed
  14. ↵
    1. Chen, W.-K.,
    2. Tsai, Y.-L.,
    3. Shibu, M. A.,
    4. Shen, C.-Y.,
    5. Chang-Lee, S. N.,
    6. Chen, R.-J.,
    7. Yao, C.-H.,
    8. Ban, B.,
    9. Kuo, W.-W. and
    10. Huang, C.-Y.
    (2018). Exercise training augments Sirt1-signaling and attenuates cardiac inflammation in D-galactose induced-aging rats. Aging 10, 4166-4174. doi:10.18632/aging.101714
    OpenUrlCrossRef
  15. ↵
    1. Chrysohoou, C.,
    2. Tsitsinakis, G.,
    3. Vogiatzis, I.,
    4. Cherouveim, E.,
    5. Antoniou, C.,
    6. Tsiantilas, A.,
    7. Tsiachris, D.,
    8. Dimopoulos, D.,
    9. Panagiotakos, D. B.,
    10. Pitsavos, C. et al.
    (2014). High intensity, interval exercise improves quality of life of patients with chronic heart failure: a randomized controlled trial. QJM Int. J. Med. 107, 25-32. doi:10.1093/qjmed/hct194
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Dabrowska, A.,
    2. Luis Venero, J.,
    3. Iwasawa, R.,
    4. Hankir, M.-K.,
    5. Rahman, S.,
    6. Boobis, A. and
    7. Hajji, N.
    (2016). PGC-1 alpha controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity (vol 7, pg 629, 2015). Aging 8, 832-832. doi:10.18632/aging.100955
    OpenUrlCrossRef
  17. ↵
    1. de Paula, M. T.,
    2. Silva, M. R. P.,
    3. Araujo, S. M.,
    4. Bortolotto, V. C.,
    5. Meichtry, L. B.,
    6. Zemolin, A. P. P.,
    7. Wallau, G. L.,
    8. Jesse, C. R.,
    9. Franco, J. L.,
    10. Posser, T. et al.
    (2016). High-fat diet induces oxidative stress and MPK2 and HSP83 gene expression in Drosophila melanogaster. Oxid. Med. Cell. Longevity 2016, 1-12. doi:10.1155/2016/4018157
    OpenUrlCrossRef
  18. ↵
    1. Diop, S. B.,
    2. Bisharat-Kernizan, J.,
    3. Birse, R. T.,
    4. Oldham, S.,
    5. Ocorr, K. and
    6. Bodmer, R.
    (2015). PGC-1/spargel counteracts high-fat-diet-induced obesity and cardiac lipotoxicity downstream of TOR and Brummer ATGL lipase. Cell Rep. 10, 1572-1584. doi:10.1016/j.celrep.2015.02.022
    OpenUrlCrossRef
  19. ↵
    1. Dumont, S.,
    2. Le Pennec, S.,
    3. Donnart, A.,
    4. Teusan, R.,
    5. Steenman, M.,
    6. Chevalier, C.,
    7. Houlgatte, R. and
    8. Savagner, F.
    (2018). Transcriptional orchestration of mitochondrial homeostasis in a cellular model of PGC-1-related coactivator-dependent thyroid tumor. Oncotarget 9, 15883-15894. doi:10.18632/oncotarget.24633
    OpenUrlCrossRef
  20. ↵
    1. Fink, M.,
    2. Callol-Massot, C.,
    3. Chu, A.,
    4. Ruiz-Lozano, P.,
    5. Belmonte, J. C. I.,
    6. Giles, W.,
    7. Bodmer, R. and
    8. Ocorr, K.
    (2009). A new method for detection and quantification of heartbeat parameters in Drosophila, zebrafish, and embryonic mouse hearts. BioTechniques 46, 101. doi:10.2144/000113078
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Fukuwatari, T.,
    2. Shibata, K.,
    3. Ishihara, K.,
    4. Fushiki, T. and
    5. Sugimoto, E.
    (2001). Elevation of blood NAD level after moderate exercise in young women and mice. J. Nutr. Sci. Vitaminol. 47, 177-179. doi:10.3177/jnsv.47.177
    OpenUrlCrossRef
  22. ↵
    1. Gambini, J.,
    2. Gomez-Cabrera, M. C.,
    3. Borras, C.,
    4. Valles, S. L.,
    5. Lopez-Grueso, R.,
    6. Martinez-Bello, V. E.,
    7. Herranz, D.,
    8. Pallardo, F. V.,
    9. Tresguerres, J. A. F.,
    10. Serrano, M. et al.
    (2011). Free NADH/NAD(+) regulates sirtuin expression. Arch. Biochem. Biophys. 512, 24-29. doi:10.1016/j.abb.2011.04.020
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Goit, R.
    (2017). Moderate intensity exercise improves heart rate variability in obese adults with type 2 diabetes. Eur. J. Neurol. 24, 452. doi:10.1016/j.clinph.2018.04.218
    OpenUrlCrossRef
  24. ↵
    1. Green, H. J.,
    2. Dusterhoft, S.,
    3. Dux, L. and
    4. Pette, D.
    (1992). Metabolite patterns related to exhaustion, recovery and transformation of chronically stimulated rabbit fast-twitch muscle. Pflugers Arch. 420, 359-366. doi:10.1007/BF00374471
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Haemmerle, G.,
    2. Moustafa, T.,
    3. Woelkart, G.,
    4. Büttner, S.,
    5. Schmidt, A.,
    6. van de Weijer, T.,
    7. Hesselink, M.,
    8. Jaeger, D.,
    9. Kienesberger, P. C.,
    10. Zierler, K. et al.
    (2011). ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1. Nat. Med. 17, U1076-U1082. doi:10.1038/nm.2439
    OpenUrlCrossRef
  26. ↵
    1. Hardy, C. M.,
    2. Birse, R. T.,
    3. Wolf, M. J.,
    4. Yu, L.,
    5. Bodmer, R. and
    6. Gibbs, A. G.
    (2015). Obesity-associated cardiac dysfunction in starvation-selected Drosophila melanogaster. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309, R658-R667. doi:10.1152/ajpregu.00160.2015
    OpenUrlCrossRefPubMed
  27. ↵
    1. Hoffmann, J.,
    2. Romey, R.,
    3. Fink, C.,
    4. Yong, L. and
    5. Roeder, T.
    (2013). Overexpression of Sir2 in the adult fat body is sufficient to extend lifespan of male and female Drosophila. Aging 5, 315-327. doi:10.18632/aging.100553
    OpenUrlCrossRefPubMed
  28. ↵
    1. Horton, J. K.,
    2. Stefanick, D. F. and
    3. Wilson, S. H.
    (2005). Involvement of poly(ADP-ribose) polymerase activity in regulating Chk1-dependent apoptotic cell death. DNA Repair 4, 1111-1120. doi:10.1016/j.dnarep.2005.05.011
    OpenUrlCrossRefPubMed
  29. ↵
    1. Huang, K.,
    2. Yan, Z.-Q.,
    3. Zhao, D.,
    4. Chen, S.-G.,
    5. Gao, L.-Z.,
    6. Zhang, P.,
    7. Shen, B.-R.,
    8. Han, H.-C.,
    9. Qi, Y.-X. and
    10. Jiang, Z.-L.
    (2015). SIRT1 and FOXO mediate contractile differentiation of vascular smooth muscle cells under cyclic stretch. Cell. Physiol. Biochem. 37, 1817-1829. doi:10.1159/000438544
    OpenUrlCrossRef
  30. ↵
    1. Huang, J.,
    2. Wang, X.,
    3. Zhu, Y.,
    4. Li, Z.,
    5. Zhu, Y.-T.,
    6. Wu, J.-C.,
    7. Qin, Z. H.,
    8. Xiang, M. and
    9. Lin, F.
    (2019). Exercise activates lysosomal function in the brain through AMPK-SIRT1-TFEB pathway. CNS Neurosci. Ther. 25, 796-807. doi:10.1111/cns.13114
    OpenUrlCrossRef
  31. ↵
    1. Jackson, G.
    (2000). Cardiac rehabilitation: exercising the heart. Int. J. Clin. Pract. 54, 71.
    OpenUrlPubMed
  32. ↵
    1. Jünger, M. A.,
    2. Rintelen, F.,
    3. Stocker, H.,
    4. Wasserman, J. D.,
    5. Végh, M.,
    6. Radimerski, T.,
    7. Greenberg, M. E. and
    8. Hafen, E.
    (2003). The Drosophila forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. J. Biol. 2, 20-20. doi:10.1186/1475-4924-2-20
    OpenUrlCrossRefPubMed
  33. ↵
    1. Kang, K.-W.,
    2. Kim, O.-S.,
    3. Lim, D.-S. and
    4. Lee, S.-K.
    (2016). GW27-e0557 Diastolic dysfunction induced by a high-fat diet is associated with mitochondrial abnormality and adenosine triphosphate levels in rats. J. Am. Coll. Cardiol. 68, C146-C147. doi:10.1016/j.jacc.2016.07.553
    OpenUrlCrossRef
  34. ↵
    1. Kayashima, Y.,
    2. Katayanagi, Y.,
    3. Tanaka, K.,
    4. Fukutomi, R.,
    5. Hiramoto, S. and
    6. Imai, S.
    (2017). Alkylresorcinols activate SIRT1 and delay ageing in Drosophila melanogaster. Sci. Rep. 7, 43679. doi:10.1038/srep43679
    OpenUrlCrossRef
  35. ↵
    1. Knight, J. R. P. and
    2. Milner, J.
    (2012). SIRT1, metabolism and cancer. Curr. Opin. Oncol. 24, 68-75. doi:10.1097/CCO.0b013e32834d813b
    OpenUrlCrossRefPubMed
  36. ↵
    1. Kobayashi, Y.,
    2. Furukawa-Hibi, Y.,
    3. Chen, C.,
    4. Horio, Y.,
    5. Isobe, K.,
    6. Ikeda, K. and
    7. Motoyama, N.
    (2005). SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int. J. Mol. Med. 16, 237-243. doi:10.3892/ijmm.16.2.237
    OpenUrlCrossRefPubMedWeb of Science
  37. ↵
    1. Koltai, E.,
    2. Szabo, Z.,
    3. Atalay, M.,
    4. Boldogh, I.,
    5. Naito, H.,
    6. Goto, S.,
    7. Nyakas, C. and
    8. Radak, Z.
    (2010). Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats. Mech. Ageing Dev. 131, 21-28. doi:10.1016/j.mad.2009.11.002
    OpenUrlCrossRefPubMedWeb of Science
  38. ↵
    1. Konecny, G. E. and
    2. Kristeleit, R. S.
    (2016). PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions. Br. J. Cancer 115, 1157-1173. doi:10.1038/bjc.2016.311
    OpenUrlCrossRef
  39. ↵
    1. Kwak, H.-B.
    (2013). Effects of aging and exercise training on apoptosis in the heart. J. Exerc. Rehabil. 9, 212-219. doi:10.12965/jer.130002
    OpenUrlCrossRef
  40. ↵
    1. Lan, F.,
    2. Weikel, K. A.,
    3. Cacicedo, J. M. and
    4. Ido, Y.
    (2017). Resveratrol-induced AMP-activated protein kinase activation is cell-type dependent: lessons from basic research for clinical application. Nutrients 9, e751. doi:10.3390/nu9070751
    OpenUrlCrossRef
  41. ↵
    1. Lavu, S.,
    2. Boss, O.,
    3. Elliott, P. J. and
    4. Lambert, P. D.
    (2008). Sirtuins - novel therapeutic targets to treat age-associated diseases. Nat. Rev. Drug Discov. 7, 841-853. doi:10.1038/nrd2665
    OpenUrlCrossRefPubMedWeb of Science
  42. ↵
    1. Li, Y. M.,
    2. Xu, S. C.,
    3. Li, J.,
    4. Zheng, L.,
    5. Feng, M.,
    6. Wang, X.,
    7. Han, K.,
    8. Pi, H.,
    9. Li, M.,
    10. Huang, X. et al.
    (2016). SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1 alpha-mediated mitochondrial biogenesis. Oncotarget 7, 29255-29274. doi:10.18632/oncotarget.8711
    OpenUrlCrossRef
  43. ↵
    1. Liu, H.-W.,
    2. Kao, H.-H. and
    3. Wu, C.-H.
    (2019). Exercise training upregulates SIRT1 to attenuate inflammation and metabolic dysfunction in kidney and liver of diabetic db/db mice. Nutr. Metab. 16, 22. doi:10.1186/s12986-019-0349-4
    OpenUrlCrossRef
  44. ↵
    1. Luu, L.,
    2. Dai, F. F.,
    3. Prentice, K. J.,
    4. Huang, X.,
    5. Hardy, A. B.,
    6. Hansen, J. B.,
    7. Liu, Y.,
    8. Joseph, J. W. and
    9. Wheeler, M. B.
    (2013). The loss of Sirt1 in mouse pancreatic beta cells impairs insulin secretion by disrupting glucose sensing. Diabetologia 56, 2010-2020. doi:10.1007/s00125-013-2946-5
    OpenUrlCrossRefPubMedWeb of Science
  45. ↵
    1. Massudi, H.,
    2. Grant, R.,
    3. Braidy, N.,
    4. Guest, J.,
    5. Farnsworth, B. and
    6. Guillemin, G. J.
    (2012). Age-associated changes in oxidative stress and NAD(+) metabolism in human tissue. PLoS ONE 7, e42357. doi:10.1371/journal.pone.0042357
    OpenUrlCrossRefPubMed
  46. ↵
    1. Morales, J. C.,
    2. Li, L. S.,
    3. Fattah, F. J.,
    4. Dong, Y.,
    5. Bey, E. A.,
    6. Patel, M.,
    7. Gao, J. and
    8. Boothman, D. A.
    (2014). Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. Crit. Rev. Eukaryot. Gene Expr. 24, 15-28. doi:10.1615/CritRevEukaryotGeneExpr.2013006875
    OpenUrlCrossRefPubMed
  47. ↵
    1. Na, J. B.,
    2. Musselman, L. P.,
    3. Pendse, J.,
    4. Baranski, T. J.,
    5. Bodmer, R.,
    6. Ocorr, K. and
    7. Cagan, R.
    (2013). A Drosophila model of high sugar diet-induced cardiomyopathy. PLoS Genet. 9, e1003175. doi:10.1371/journal.pgen.1003175
    OpenUrlCrossRefPubMed
  48. ↵
    1. Palu, R. A. S. and
    2. Thummel, C. S.
    (2016). Sir2 acts through hepatocyte nuclear factor 4 to maintain insulin signaling and metabolic homeostasis in Drosophila. PLoS Genet. 12, e1005978. doi:10.1371/journal.pgen.1005978
    OpenUrlCrossRef
  49. ↵
    1. Pang, J.,
    2. Cui, J.,
    3. Gong, H.,
    4. Xi, C. and
    5. Zhang, T.-M.
    (2015). Effect of NAD on PARP-mediated insulin sensitivity in oleic acid treated hepatocytes. J. Cell. Physiol. 230, 1607-1613. doi:10.1002/jcp.24907
    OpenUrlCrossRefPubMed
  50. ↵
    1. Puigserver, P.,
    2. Wu, Z.,
    3. Park, C. W.,
    4. Graves, R.,
    5. Wright, M. and
    6. Spiegelman, B. M.
    (1998). A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839. doi:10.1016/S0092-8674(00)81410-5
    OpenUrlCrossRefPubMedWeb of Science
  51. ↵
    1. Reis, T.,
    2. Van Gilst, M. R. and
    3. Hariharan, I. K.
    (2010). A buoyancy-based screen of drosophila larvae for fat-storage mutants reveals a role for Sir2 in coupling fat storage to nutrient availability. PLoS Genet. 6, e1001206. doi:10.1371/journal.pgen.1001206
    OpenUrlCrossRefPubMed
  52. ↵
    1. Rizki, G.,
    2. Iwata, T. N.,
    3. Li, J.,
    4. Riedel, C. G.,
    5. Picard, C. L.,
    6. Jan, M.,
    7. Murphy, C. T. and
    8. Lee, S. S.
    (2011). The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXO. PLoS Genet. 7, e1002235. doi:10.1371/journal.pgen.1002235
    OpenUrlCrossRefPubMed
  53. ↵
    1. Roberts, C. K.,
    2. Barnard, R. J.,
    3. Sindhu, R. K.,
    4. Jurczak, M.,
    5. Ehdaie, A. and
    6. Vaziri, N. D.
    (2006). Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metab. Clin. Exp. 55, 928-934. doi:10.1016/j.metabol.2006.02.022
    OpenUrlCrossRefPubMedWeb of Science
  54. ↵
    1. Rodgers, J. T.,
    2. Lerin, C.,
    3. Haas, W.,
    4. Gygi, S. P.,
    5. Spiegelman, B. M. and
    6. Puigserver, P.
    (2005). Nutrient control of glucose homeostasis through a complex of PGC-1 alpha and SIRT1. Nature 434, 113-118. doi:10.1038/nature03354
    OpenUrlCrossRefPubMedWeb of Science
  55. ↵
    1. Rorth, P.
    (1996). A modular misexpression screen in Drosophila detecting tissue-specific phenotypes. Proc. Natl. Acad. Sci. USA 93, 12418-12422. doi:10.1073/pnas.93.22.12418
    OpenUrlAbstract/FREE Full Text
  56. ↵
    1. Sauve, A. A.
    (2008). NAD(+) and vitamin B(3): from metabolism to therapies. J. Pharmacol. Exp. Ther. 324, 883-893. doi:10.1124/jpet.107.120758
    OpenUrlAbstract/FREE Full Text
  57. ↵
    1. Sibouakaz, D.,
    2. Othmani-Mecif, K.,
    3. Fernane, A.,
    4. Taghlit, A.,
    5. Rami, W. and
    6. Benazzoug, Y.
    (2016). Oxidative stress induced by high fat diet on heart biochemical parameters of pre-pubertal female and male rabbits. Acta Physiol. 217, 112-113. doi:10.1016/s1878-6480(17)30479-2
    OpenUrlCrossRef
  58. ↵
    1. Slade, J. D. and
    2. Staveley, B. E.
    (2016). Extended longevity and survivorship during amino-acid starvation in a Drosophila Sir2 mutant heterozygote. Genome 59, 311-318. doi:10.1139/gen-2015-0213
    OpenUrlCrossRef
  59. ↵
    1. Stanley, S. H.,
    2. Ng, S. M. and
    3. Laugharne, J. D. E.
    (2019). The ‘Fit for Life’ exercise programme: improving the physical health of people with a mental illness. Psychol. Health Med. 24, 187-192. doi:10.1080/13548506.2018.1530366
    OpenUrlCrossRef
  60. ↵
    1. Tang, B. L.
    (2016). Sirt1 and the Mitochondria. Mol. Cells 39, 87-95. doi:10.14348/molcells.2016.2318
    OpenUrlCrossRefPubMed
  61. ↵
    1. Tinkerhess, M. J.,
    2. Ginzberg, S.,
    3. Piazza, N. and
    4. Wessells, R. J.
    (2012). Endurance training protocol and longitudinal performance assays for Drosophila melanogaster. J. Vis. Exp. doi:10.3791/3786
    OpenUrlCrossRef
  62. ↵
    1. Touati, S.,
    2. Montezano, A. C. I.,
    3. Meziri, F.,
    4. Riva, C.,
    5. Touyz, R. M. and
    6. Laurant, P.
    (2015). Exercise training protects against atherosclerotic risk factors through vascular NADPH oxidase, extracellular signal-regulated kinase 1/2 and stress-activated protein kinase/c-Jun N-terminal kinase downregulation in obese rats. Clin. Exp. Pharmacol. Physiol. 42, 179-185. doi:10.1111/1440-1681.12338
    OpenUrlCrossRef
  63. ↵
    1. Vaduganathan, M.,
    2. Claggett, B. L.,
    3. Chatterjee, N. A.,
    4. Anand, I. S.,
    5. Sweitzer, N. K.,
    6. Fang, J. C.,
    7. O'Meara, E.,
    8. Shah, S. J.,
    9. Hegde, S. M.,
    10. Desai, A. S. et al.
    (2018). Sudden death in heart failure with preserved ejection fraction: a competing risks analysis from the TOPCAT trial. JACC Heart Failure 6, 653-661. doi:10.1016/j.jchf.2018.02.014
    OpenUrlAbstract/FREE Full Text
  64. ↵
    1. Voulgari, C.,
    2. Pagoni, S.,
    3. Vinik, A. and
    4. Poirier, P.
    (2013). Exercise improves cardiac autonomic function in obesity and diabetes. Metab. Clin. Exp. 62, 609-621. doi:10.1016/j.metabol.2012.09.005
    OpenUrlCrossRefPubMed
  65. ↵
    1. Wang, Y. T. and
    2. Xu, D. Y.
    (2017). Effects of aerobic exercise on lipids and lipoproteins. Lipids Health Dis. 16, 132. doi:10.1186/s12944-017-0515-5
    OpenUrlCrossRefPubMed
  66. ↵
    Water exercise safe for troubled hearts. (2011). Harvard Heart Letter: from Harvard Medical School, Vol. 22, p. 6. Giuseppe Marazzi.
    OpenUrl
  67. ↵
    1. Wen, D.-T.,
    2. Zheng, L.,
    3. Ni, L.,
    4. Wang, H.,
    5. Feng, Y. and
    6. Zhang, M.
    (2016). The expression of CG9940 affects the adaptation of cardiac function, mobility, and lifespan to exercise in aging Drosophila. Exp. Gerontol. 83, 6-14. doi:10.1016/j.exger.2016.07.006
    OpenUrlCrossRef
  68. ↵
    1. Wen, D.-T.,
    2. Zheng, L.,
    3. Yang, F.,
    4. Li, H.-Z. and
    5. Hou, W.-Q.
    (2018). Endurance exercise prevents high-fat-diet induced heart and mobility premature aging and dsir2 expression decline in aging Drosophila. Oncotarget 9, 7298-7311. doi:10.18632/oncotarget.23292
    OpenUrlCrossRef
  69. ↵
    1. Wessells, R. J.,
    2. Fitzgerald, E.,
    3. Cypser, J. R.,
    4. Tatar, M. and
    5. Bodmer, R.
    (2004). Insulin regulation of heart function in aging fruit flies. Nat. Genet. 36, 1275-1281. doi:10.1038/ng1476
    OpenUrlCrossRefPubMedWeb of Science
  70. ↵
    1. Whitaker, R.,
    2. Faulkner, S.,
    3. Miyokawa, R.,
    4. Burhenn, L.,
    5. Henriksen, M.,
    6. Wood, J. G. and
    7. Helfand, S. L.
    (2013). Increased expression of Drosophila Sir2 extends life span in a dose-dependent manner. Aging 5, 682-691. doi:10.18632/aging.100599
    OpenUrlCrossRefPubMed
  71. ↵
    1. Yang, S. J.,
    2. Choi, J. M.,
    3. Chang, E.,
    4. Park, S. W. and
    5. Park, C.-Y.
    (2014). Sirt1 and Sirt6 mediate beneficial effects of rosiglitazone on hepatic lipid accumulation. PLoS ONE 9, e105456. doi:10.1371/journal.pone.0105456
    OpenUrlCrossRef
  72. ↵
    1. Yoshino, J.,
    2. Mills, K. F.,
    3. Yoon, M. J. and
    4. Imai, S.-I.
    (2011). Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528-536. doi:10.1016/j.cmet.2011.08.014
    OpenUrlCrossRefPubMedWeb of Science
  73. ↵
    1. Zhang, Z.-F.,
    2. Fan, S.-H.,
    3. Zheng, Y.-L.,
    4. Lu, J.,
    5. Wu, D.-M.,
    6. Shan, Q. and
    7. Hu, B.
    (2014). Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice. Biochem. Pharmacol. 91, 74-86. doi:10.1016/j.bcp.2014.07.002
    OpenUrlCrossRefPubMed
  74. ↵
    1. Zheng, L.,
    2. Feng, Y.,
    3. Wen, D. T.,
    4. Wang, H. and
    5. Wu, X. S.
    (2015). Fatiguing exercise initiated later in life reduces incidence of fibrillation and improves sleep quality in Drosophila. Age 37, 12. doi:10.1007/s11357-015-9816-7
    OpenUrlCrossRef
  75. ↵
    1. Zheng, L.,
    2. Li, Q. F.,
    3. Ni, L.,
    4. Wang, H.,
    5. Ruan, X. C. and
    6. Wu, X. S.
    (2017). Lifetime regular exercise affects the incident of different arrhythmias and improves organismal health in aging female Drosophila melanogaster. Biogerontology 18, 97-108. doi:10.1007/s10522-016-9665-5
    OpenUrlCrossRef
Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

RSSRSS

Keywords

  • Heart
  • dSir2
  • NAD+
  • PGC-1α
  • Exercise
  • High-fat diet

 Download PDF

Email

Thank you for your interest in spreading the word on Biology Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Endurance exercise resistance to lipotoxic cardiomyopathy is associated with cardiac NAD+/dSIR2/PGC-1α pathway activation in old Drosophila
(Your Name) has sent you a message from Biology Open
(Your Name) thought you would like to see the Biology Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Research Article
Endurance exercise resistance to lipotoxic cardiomyopathy is associated with cardiac NAD+/dSIR2/PGC-1α pathway activation in old Drosophila
Deng-Tai Wen, Lan Zheng, Jin-xiu Li, Dan Cheng, Yang Liu, Kai Lu, Wen-qi Hou
Biology Open 2019 8: bio044719 doi: 10.1242/bio.044719 Published 17 October 2019
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Research Article
Endurance exercise resistance to lipotoxic cardiomyopathy is associated with cardiac NAD+/dSIR2/PGC-1α pathway activation in old Drosophila
Deng-Tai Wen, Lan Zheng, Jin-xiu Li, Dan Cheng, Yang Liu, Kai Lu, Wen-qi Hou
Biology Open 2019 8: bio044719 doi: 10.1242/bio.044719 Published 17 October 2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article Navigation

  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • Acknowledgements
    • Footnotes
    • References
  • Figures & tables
  • Info & metrics
  • eLetters
  • PDF

Related articles

Cited by...

More in this TOC section

  • Local adaptation in thermal tolerance for a tropical butterfly across ecotone and rainforest habitats
  • Validating accelerometry-derived proxies of energy expenditure using the doubly labelled water method in the smallest penguin species
  • Three functional polymorphisms in CCDC170 were associated with osteoporosis phenotype
Show more RESEARCH ARTICLE

Similar articles

Other journals from The Company of Biologists

Development

Journal of Cell Science

Journal of Experimental Biology

Disease Models & Mechanisms

Advertisement

Biology Open and COVID-19

We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.

Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.


Future Leader Review - Cardiac myosin super relaxation

A new Future Leader Review by Manuel Schmid and Christopher Toepfer discusses the rapidly-expanding field of myosin super relaxation in the context of cardiovascular disease. Read the full Review and their accompanying interview.

Find out more about our Future Leader Reviews – they are an exclusive opportunity for early-career researchers who want to establish themselves in their field.


An interview with Roberta Azzarelli

In an interview, first author Roberta Azzarelli discusses her 3D model of glioblastoma and shares her thoughts on how to improve the professional lives of early-career researchers: formal mentorship programmes, a clearly structured career path and taking part in initiatives such as the Node Network.


News from our sister journals

Development continues to run a successful new webinar series, Development presents…, while Journal of Cell Science has recently welcomed Esperanza Agullo-Pascual as FocalPlane’s new Community Manager. Journal of Experimental Biology’s new special issue highlights the role of comparative biology in tackling climate change and Liz Patton, the new Editor-in-Chief of Disease Models & Mechanisms, sets out her visions and priorities.

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Interviews
  • Sign up for alerts

About us

  • About BiO
  • Editors and Board
  • Editor biographies
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contact

  • Contact BiO
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992